No Data
No Data
Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration With Multi-Billion-Dollar Software Provider
Petros Pharmaceuticals Partners With AI Firm for New OTC Medication
Petros Pharmaceuticals Enters Into AI Licensing Agreement With Leading Multi-Billion-Dollar Software Provider
AI software expected to further enable Petros's efforts to make STENDRA the first ED product to be offered over the counterNEW YORK, NY / ACCESSWIRE / February 14, 2024 / Petros Pharmaceuticals, Inc.
MQ, ORMP and EXAI Are Among Pre Market Gainers
PLUG, PXLW and ASMB Are Among Pre Market Gainers
Compugen, Iterum Therapeutics Among Healthcare Movers
No Data
HH1000 : what fda news for ptpi?